And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Urine samples from 20 and 44 patients with bladder cancer undergoing RC were prospectively collected for retrospective ...

A YOUNG woman who thought nothing of her urinary tract ... every day as her bladder was disconnected from her kidney. She said: "There is a high chance it [the cancer] will come back.

A woman who thought she just had a UTI was diagnosed with a rare tissue cancer and has now undergone ... hospital and had over 2L of urine drained from her bladder and doctors told her if she ...

Patients with advanced bladder cancer that had spread to other parts of the body (metastasized) have responded well in a phase I clinical trial of an investigational drug, TYRA-300. The drug ...

He has accepted the fact that, without a bladder, he’ll have to wear a bag on his side for the rest of ... can cause the same symptoms as bladder cancer. The most common sign is blood in the urine.

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the main goal in a confirmatory trial.

With its lead candidate in a phase 3 trial for a rare eye cancer, Aura Biosciences is looking to expand the drug into a more common disease: bladder cancer. In a phase 1 trial in patients with non ...